Tourism organization "Wonderful Copenhagen" has announced in a press release that the European Association for the Study of Diabetes (EASD) conference will be held at the Bella Center Copenhagen in Ørestad, Copenhagen, in 2028.

“We are really pleased that, together with Bellagroup and a number of partners, we have won the right to host the EASD in the capital in 2028 in fierce competition with other European cities,” Wonderful Copenhagen’s CEO, Søren Tegen Pedersen, comments in the press release.

According to the tourism organization, around 15,000 people are expected to attend the conference which will take place in September 2028.

The EASD conference is an annual event where pharmaceutical companies typically present new data on a number of their potential diabetes and weight loss drugs.

That is why it usually attracts a lot of attention.

Last year, Novo Nordisk presented additional data on Wegovy (semaglutide) and the drug candidates zenagamtide, which until recently was known as amycretin, and Cagrisema (cagrilintide, semaglutide), while US company Eli Lilly presented new data on the candidate orforglipron.

The EASD conference changes location every year and was held last year in the Austrian capital Vienna, while this year it will take place in Milan, Italy. In 2027, it will visit the Hungarian capital Budapest before coming to Copenhag

After 22 years, Novo Nordisk’s home is set to host the European Diabetes Conference (EASD 2028), a major milestone for Novo.